Hims & Hers shared users’ health information with social media companies despite assuring privacy, according to a lawsuit.
FTC Files Lawsuit Against Hims & Hers The Federal Trade Commission filed a lawsuit on Wednesday against Hims & Hers, alleging that the telemedicine company disclosed users’ health data to online advertisers, despite assurances of privacy. They also claimed the company used misleading billing and cancellation tactics. According to the FTC, sensitive health information was […]
Stocks with the largest after-hours movements: Hims & Hers, Gitlab, Cleanspark, Webtoon Entertainment, and others.
Market Reactions and Company Updates After the market closed, several companies experienced notable fluctuations in their stock prices: Hims & Hers Health — The telehealth provider’s shares fell over 6%. The company projected an adjusted EBITDA for the ongoing quarter between $35 million and $55 million, which was much lower than the $70 million analysts […]
Midday stock movements: Intel, AMD, Charter, Hims & Hers, Eli Lilly and others
Here’s a look at companies making notable moves in intraday trading: Comcast, the parent company of NBCUniversal, saw its stock drop almost 8%. This came after Deutsche Bank changed its rating from buy to hold, expressing concerns over sustainable earnings and cash flow growth. Charter Communications experienced a significant decline as well, falling 23% after […]
Hims Stock Achieves Record Week as Novo Agreement Boosts Confidence
Hims & Hers Health Stock Surges After Novo Nordisk Partnership (Bloomberg) — Shares of Hims & Hers Health saw an impressive rise this week, hitting their highest level ever after the company announced a partnership with Novo Nordisk A/S, bringing fresh optimism regarding its future in weight-loss medications. The San Francisco-based firm experienced a 57% […]
Hims & Hers launches blood test for 50 different cancers
New Blood Test Detects Cancer Before Symptoms Appear Waiting for cancer symptoms to emerge may soon be a thing of the past. This week, the telemedicine service Hims & Hers launched a blood test that screens for multiple types of cancer, even those without standard checkups. “Catching cancer early usually provides more treatment options and […]
Stocks with the largest changes in after-hours trading: Palantir, Hims & Hers Health, Clorox, and others
After-Hours Trading Highlights Let’s dive into some companies making headlines in after-hours trading. Palantir Technologies saw a 1% increase in its stock after it reported quarterly results that surpassed Wall Street forecasts, with government revenue jumping 52% compared to a year earlier. The company posted adjusted earnings of 21 cents per share on sales of […]
Hims & Hers Health’s Q3 Sales Exceed Expectations
Hims & Hers Health Reports Q3 2025 Results Telemedicine firm Hims & Hers Health (NYSE:HIMS) has unveiled its third-quarter results for 2025, showcasing a revenue increase of 49.2% year-over-year, totaling $599 million. However, its revenue forecast for the upcoming quarter, set at $615 million, fell 2.6% short of analyst predictions. Also, the company reported GAAP […]
Before Q3 Earnings, Let’s Examine the Owners of Hims & Hers Health Stock (HIMS)
Him’s & Hers Health Financial Update Him’s & Hers Health (HIMS), a telemedicine platform, is set to release its third quarter financial results on Monday, November 3rd, after the market closes. Recently, the stock has dipped by 22% over the last month, mainly due to insider selling, but it’s still holding on with a year-to-date […]
Midday stock movements: Webtoon Entertainment, Steel Dynamics, Hims & Hers and others
Market Update: Key Moves in Various Companies In recent trading news, Webtoon Entertainment’s stock surged by 31% following an agreement to develop a digital comics platform for Disney. Additionally, they will be selling a 2% stake to the media giant. On the flip side, Emerson Electric saw its shares drop by 4.5%. The company’s management […]
Hims Stock Increases as FDA Releases “Green List,” Novo Nordisk Shares Decrease
Shares of HIMS & HERS (HIMS) increased by 2.6% on Monday following the FDA’s release of a “green list” of global suppliers offering ingredients that meet GLP-1 standards. This announcement indicates that the company will begin to take on compound interest, allowing them to gather active ingredients and create customized versions of GLP-1 weight loss […]